NCT02261675

Brief Summary

The study was designed to define the interaction of intravenous infusion of dexmedetomidine, an a2-adrenergic agonist, and sevoflurane in children having surgery by using the minimum alveolar concentration which can block adrenergic and cardiovascular responses to incision(MACbar) of sevoflurane as the measure of anesthetic potency.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 10, 2014

Completed
Last Updated

October 10, 2014

Status Verified

October 1, 2014

Enrollment Period

1.1 years

First QC Date

October 2, 2014

Last Update Submit

October 7, 2014

Conditions

Keywords

dexmedetomidinesevofluraneMAC bardrug interactionanesthesia

Outcome Measures

Primary Outcomes (1)

  • the end-tidal sevoflurane concentration to blockade adrenergic response to surgical incision in 50% of children (MACBAR)

    A predetermined steady-state end-tidal sevoflurane concentration(4%) was maintained for at least 15 min before skin incision.we observed the change in Mean Blood Pressure or Heart rate to determined the next end-tidal sevoflurane concentration.Followed the modified Dixon up and down method to obtain MACBAR of every child.The MACBAR of sevoflurane and its 95% confidence interval were calculated by Sum Average method.

    at once before incision and 5 min period after incision

Study Arms (3)

control group

NO INTERVENTION

children undergoing selective lower abdominal surgery received saline before induction

D1 group

EXPERIMENTAL

children undergoing selective lower abdominal surgery received a bolus dose of 0.5 µg/kg dexmedetomidine followed by a continuous infusion of 0.5 µg/kg /h before induction

Drug: dexmedetomidine

D2 group

EXPERIMENTAL

children undergoing selective lower abdominal surgery received a bolus dose of 1.0µg/kg dexmedetomidine followed by a continuous infusion of 1.0 µg/kg /h before induction

Drug: dexmedetomidine

Interventions

children received intravenous infusion with a bolus dose dexmedetomidine and followed by a continuous infusion before induction. use sevoflurane for induction and a steady-state end-tidal sevoflurane concentration was maintained for at least 15 min before skin incision.

Also known as: precedex
D1 groupD2 group

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • aged 2 to 6 yr
  • American Society of anesthesiologists I or II
  • scheduled to have general anesthesia and to have skin incisions on the abdomen

You may not qualify if:

  • anemia or abnormal preoperative electrolyte concentrations
  • a history of cardiovascular or central nervous system diseases
  • a history of pulmonary disease
  • known hepatic or renal disease
  • a body weight exceeding 50% of the upper limit of ideal body weight for height
  • taking drugs with cardiovascular or central nervous system effects
  • use of any experimental drug within the past 30 days
  • allergy to any drug that may be administered during the study
  • exposure to general anesthesia within the previous 7 days
  • second- or third-degree atrioventricular block
  • taking drugs preoperatively that would interfere with MAC determination(e.g.,opioids or sedatives)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Albertin A, Casati A, Bergonzi P, Fano G, Torri G. Effects of two target-controlled concentrations (1 and 3 ng/ml) of remifentanil on MAC(BAR) of sevoflurane. Anesthesiology. 2004 Feb;100(2):255-9. doi: 10.1097/00000542-200402000-00012.

MeSH Terms

Interventions

Dexmedetomidine

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Xuan Ke Liu, Ph.d

    Departmeng of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Department of Anesthesiology, First Affiliated Hospital, Sun Yat-Sen University

Study Record Dates

First Submitted

October 2, 2014

First Posted

October 10, 2014

Study Start

January 1, 2013

Primary Completion

February 1, 2014

Study Completion

April 1, 2014

Last Updated

October 10, 2014

Record last verified: 2014-10